Walking Fish Therapeutics, Inc.

Walking Fish Therapeutics, Inc. is a biotechnology startup headquartered in the United States, founded in 2019. The company's slogan "Engineering B Cell‐Based Protein Factories to Treat Serious Diseases" encapsulates its focus on creating a broad B cell platform for addressing oncology, regenerative medicine, autoimmune diseases, and recombinant antibody production. The WFT team, backed by experienced researchers, is dedicated to pioneering a new approach to treating severe diseases through critical advances in engineering technologies and a deep understanding of B cell biology. The company recently secured a notable $23.00M Series A investment on 16 February 2022, attracting backing from prominent investors including First Spark Ventures, Northpond Ventures, and Terra Magnum Capital Partners. Walking Fish Therapeutics' innovative approach and seasoned team position it as a compelling player in the biotechnology space, poised to make significant strides in addressing serious diseases.